Novel production prescription and process of carbamazepine tablets

Abstract

The invention discloses a novel production prescription and process of carbamazepine tablets. The novel production prescription and the process are based on the characteristics of starch, cellulose and dextrin to control the release speed of a main drug in a human body, ensure the consistency of the blood concentration in the human body and an originally researched drug, and the product quality is improved, the release speed of the main drug is controlled and the safety of drug use is ensured on the basis of simplification of the production process. Specifically, according to the disintegration characteristics of different auxiliary materials such as starch, cellulose and dextrin, a framework structure for controlling the main drug to be gradually released in a human body is constructed, namely, the disintegration speeds of the drug in different environments in the human body are controlled, in general, the release speed of the main drug in the human body is too fast, so that the blood concentration in the human body exceeds the upper limit of a treatment window, and the poisoning of a user and the generation of a large number of adverse reactions are caused. The release degree and the exposure amount of the drug in the human body are strictly controlled, the release of the drug in the human body ensures that the blood concentration in the human body is consistent with that of the originally researched drug.

Description

technical field [0001] The invention relates to the related field of carbamazepine tablet prescription drugs, in particular to a novel production prescription and process of carbamazepine tablet. Background technique [0002] Carbamazepine tablets have the following therapeutic effects, 1. Complex partial seizures (also known as psychomotor seizures or temporal lobe epilepsy), generalized tonic-paroxysmal seizures, the above two mixed seizures, or other partial or generalized seizures seizures; not effective for typical or atypical absence seizures, myotonic seizures, or absence-tonic seizures. 2. For the onset of trigeminal neuralgia and glossopharyngeal neuralgia, it can also be used as a long-term preventive drug after the relief of trigeminal neuralgia. It can also be used for tabes dorsalis and multiple sclerosis, diabetic peripheral neuralgia, pain in affected limbs and post-traumatic neuralgia and post-herpetic neuralgia. 3. Prevention or treatment of mania-depressi...

Images